City University of New York

Spring Forward

Have you had a hard time finding internships related to your major or career interests? Do you meet our eligibility requirements? Are you ready to show off to employers everything you are learning at ...
PV Tech

SMA Solar opens US$92 million Gigawatt Factory in Germany

The facility covers approximately 495,000 square feet, with around 221,000 square feet of floor space. Image: SMA Solar Technology. Germany-headquartered inverter manufacturer SMA Solar Technology has ...
rarediseaseadvisor

FDA Approves Apitegromab, First Muscle-Targeting Therapy for Children and Adults With SMA

Patients receiving apitegromab in the SAPPHIRE trial experienced clinically meaningful improvements in motor function compared with placebo. Scholar Rock announced that the US Food and Drug ...
BioPharma Dive

Scholar Rock SMA drug approved by FDA

The Food and Drug Administration has approved a new kind of medication for the rare genetic disease spinal muscular atrophy. Called apitegromab and to be sold as Isembyld, the treatment on Friday was ...
STAT

Scholar Rock wins FDA approval for first drug to target SMA muscle loss

Jonathan Wosen is STAT’s West Coast biotech & life sciences reporter. You can reach Jonathan on Signal at jwosen.27. Scholar Rock on Friday received Food and Drug Administration approval for the first ...
mda

FDA Approves Isembyld (apitegromab-mstn), the First and Only Muscle-Targeted Therapy for Spinal Muscular Atrophy, Marking a New Milestone in SMA Treatment

New York, Friday, September 11, 2026 – The Muscular Dystrophy Association (MDA) marks another milestone for the neuromuscular community with the U.S. Food and Drug Administration (FDA) approval of ...